RHUMBLINE ADVISERS - STEMLINE THERAPEUTICS CVR ownership

STEMLINE THERAPEUTICS CVR's ticker is and the CUSIP is 858CVR107. A total of 1 filers reported holding STEMLINE THERAPEUTICS CVR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of STEMLINE THERAPEUTICS CVR
ValueSharesWeighting
Q2 2021$055,379
-4.0%
0.00%
Q1 2021$057,670
+12.0%
0.00%
Q4 2020$051,4700.0%0.00%
Q3 2020$051,470
-10.8%
0.00%
Q2 2020$057,6700.00%
Other shareholders
STEMLINE THERAPEUTICS CVR shareholders Q3 2020
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 51,470$00.00%
View complete list of STEMLINE THERAPEUTICS CVR shareholders